109 related articles for article (PubMed ID: 21356276)
21. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.
Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G
Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319
[TBL] [Abstract][Full Text] [Related]
22. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of trichostatin A on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT-20 cells.
Nakada Y; Kageyama K; Sugiyama A; Desaki R; Takayasu S; Niioka K; Murasawa S; Ishigame N; Asari Y; Iwasaki Y; Daimon M
Endocr J; 2015; 62(12):1083-90. PubMed ID: 26497760
[TBL] [Abstract][Full Text] [Related]
24. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas.
da Rocha AA; Giorgi RR; de Sa SV; Correa-Giannella ML; Fortes MA; Cavaleiro AM; Machado MC; Cescato VA; Bronstein MD; Giannella-Neto D
Pituitary; 2006; 9(2):83-92. PubMed ID: 16832584
[TBL] [Abstract][Full Text] [Related]
26. Differential gene expression by fiber-optic beadarray and pathway in adrenocorticotrophin-secreting pituitary adenomas.
Jiang ZQ; Gui SB; Zhang YZ
Chin Med J (Engl); 2010 Dec; 123(23):3455-61. PubMed ID: 22166531
[TBL] [Abstract][Full Text] [Related]
27. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.
Stefaneanu L; Kovacs K; Horvath E; Lloyd RV
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):107-13. PubMed ID: 1651583
[TBL] [Abstract][Full Text] [Related]
28. Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas.
Dieterich KD; Gundelfinger ED; Lüdecke DK; Lehnert H
J Clin Endocrinol Metab; 1998 Sep; 83(9):3327-31. PubMed ID: 9745449
[TBL] [Abstract][Full Text] [Related]
29. AZA-deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors.
Cassarino MF; Sesta A; Pagliardini L; Losa M; Lasio G; Cavagnini F; Pecori Giraldi F
Pituitary; 2014 Oct; 17(5):464-9. PubMed ID: 24085685
[TBL] [Abstract][Full Text] [Related]
30. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
Fukuoka H; Cooper O; Ben-Shlomo A; Mamelak A; Ren SG; Bruyette D; Melmed S
J Clin Invest; 2011 Dec; 121(12):4712-21. PubMed ID: 22105169
[TBL] [Abstract][Full Text] [Related]
31. Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma.
Tateno T; Izumiyama H; Doi M; Akashi T; Ohno K; Hirata Y
Endocr J; 2007 Dec; 54(5):777-82. PubMed ID: 17917309
[TBL] [Abstract][Full Text] [Related]
32. High expression of the POU factor Brn3a in aggressive neuroendocrine tumors.
Leblond-Francillard M; Picon A; Bertagna X; de Keyzer Y
J Clin Endocrinol Metab; 1997 Jan; 82(1):89-94. PubMed ID: 8989239
[TBL] [Abstract][Full Text] [Related]
33. Different levels of various glucocorticoid-regulated genes in corticotroph adenomas.
Evang JA; Bollerslev J; Casar-Borota O; Lekva T; Ramm-Pettersen J; Berg JP
Endocrine; 2013 Aug; 44(1):220-7. PubMed ID: 23315031
[TBL] [Abstract][Full Text] [Related]
34. Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries.
de Keyzer Y; Bertagna X; Lenne F; Girard F; Luton JP; Kahn A
J Clin Invest; 1985 Nov; 76(5):1892-8. PubMed ID: 2997296
[TBL] [Abstract][Full Text] [Related]
35. Targeting the ERK pathway for the treatment of Cushing's disease.
Zhang D; Bergsneider M; Wang MB; Heaney AP
Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
[TBL] [Abstract][Full Text] [Related]
36. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
[TBL] [Abstract][Full Text] [Related]
37. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
38. Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro.
Suda T; Tozawa F; Yamada M; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Demura H; Shizume K
J Clin Invest; 1988 Jul; 82(1):110-4. PubMed ID: 2839542
[TBL] [Abstract][Full Text] [Related]
39. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
40. Effects of antisense DNA on POMC mRNA and ACTH levels in cultured human corticotroph adenoma cells.
Woloschak M; Post K; Roberts JL
J Endocrinol Invest; 1994 Nov; 17(10):817-9. PubMed ID: 7699217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
